Rep. Mariannette Miller-Meeks, U.S. Representative for Iowa's 1st District | Official U.S. House headshot
Rep. Mariannette Miller-Meeks, U.S. Representative for Iowa's 1st District | Official U.S. House headshot
On June 25, 2025, Congresswoman Mariannette Miller-Meeks hosted a Capitol Hill briefing to highlight the impact of artificial intelligence (AI) on healthcare. The event brought together members of Congress, staff, and healthcare leaders to discuss how AI is improving clinical practice and patient care.
The briefing focused on responsible AI use that supports clinical judgment while maintaining privacy and ethics. Discussions included regulatory challenges, liability protections, reimbursement issues, and venture capital's role in scaling AI tools.
Congresswoman Miller-Meeks stated, "Artificial intelligence holds tremendous potential to improve the effectiveness and efficiency of healthcare delivery." She emphasized the need for the federal government to learn from AI pioneers in healthcare. During the roundtable, innovators shared insights on using AI for early detection of heart disease and diabetes-related vision conditions.
Dr. Jesse Ehrenfeld from the American Medical Association noted that two-thirds of U.S. physicians use AI tools to enhance workflow efficiency without replacing clinical judgment. Dr. Michael Abramoff highlighted how autonomous AI can close care gaps by enabling early detection in primary care settings.
Dr. Campbell Rogers of HeartFlow discussed the importance of creating AI-specific reimbursement frameworks to make innovations accessible to patients. Todd Klein from Revolution Growth spoke about the role of investors in scaling transformative technologies like healthcare AI responsibly.
Key takeaways from the briefing included aligning FDA clearance with CMS payment for access through reimbursement and engaging healthcare startups as resources for Congress and other agencies. The event underscored the opportunity for the U.S. to lead in safe and scalable AI deployment in healthcare if supported by a conducive regulatory environment.